• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一级预防治疗时代植入式心脏复律除颤器接受者的生活质量

Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era.

作者信息

Groeneveld Peter W, Matta Mary A, Suh Janice J, Yang Feifei, Shea Judy A

机构信息

Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.

出版信息

Pacing Clin Electrophysiol. 2007 Apr;30(4):463-71. doi: 10.1111/j.1540-8159.2007.00694.x.

DOI:10.1111/j.1540-8159.2007.00694.x
PMID:17437568
Abstract

BACKGROUND

Although patients receiving implantable cardioverter-defibrillators (ICDs) for primary prevention of sudden cardiac death are the fastest growing segment of the ICD recipient population, the quality-of-life (QOL) effects of the ICD among primary prevention patients are not well understood. The purpose of this study was to measure and compare the health-related QOL among primary and secondary prevention ICD recipients, and to determine predictive factors for high or low QOL in each group.

METHODS

Forty-five primary prevention and 75 secondary prevention ICD recipients receiving routine care in electrophysiology clinics within the University of Pennsylvania Health System were assessed using several well-validated general and ICD-specific QOL instruments.

RESULTS

Between primary and secondary prevention patients, there were no significant differences in EuroQol 5D (medians: 0.84 vs 0.84, P = 0.71), Health Utilities Index (medians: 0.88 vs 0.85, P = 0.95), Short Form-12 aggregate physical summary (means: 45 vs 46, P = 0.64), and Short Form-12 aggregate mental summary (means: 46 vs 47, P = 0.93) scores. Both primary and secondary prevention patients viewed their devices favorably according to the Florida Patient Acceptance Survey scale, with no significant differences between group means (80 vs 83, P = 0.71). However, substantial fractions of both primary and secondary prevention recipients had particular concerns about lifting (40%), sexual activity (19%), and driving (14%).

CONCLUSIONS

QOL does not significantly differ between primary prevention and secondary prevention ICD recipients. Device recipients had comparable QOL to published, nationwide QOL estimates among non-ICD patients of similar age. The ICD was highly acceptable to most primary and secondary prevention patients.

摘要

背景

尽管接受植入式心脏复律除颤器(ICD)进行心脏性猝死一级预防的患者是ICD接受者群体中增长最快的部分,但ICD对一级预防患者生活质量(QOL)的影响尚未得到充分了解。本研究的目的是测量和比较一级和二级预防ICD接受者的健康相关生活质量,并确定每组中生活质量高或低的预测因素。

方法

使用几种经过充分验证的一般和特定于ICD的生活质量工具,对宾夕法尼亚大学医疗系统电生理诊所接受常规护理的45名一级预防和75名二级预防ICD接受者进行评估。

结果

在一级和二级预防患者之间,欧洲五维健康量表(中位数:0.84对0.84,P = 0.71)、健康效用指数(中位数:0.88对0.85,P = 0.95)、简明健康调查问卷12项身体综合评分(均值:45对46,P = 0.64)和简明健康调查问卷12项心理综合评分(均值:46对47,P = 0.93)得分均无显著差异。根据佛罗里达患者接受度调查量表,一级和二级预防患者对其设备的评价都很高,两组均值之间无显著差异(80对83,P = 0.71)。然而,一级和二级预防接受者中相当一部分人对提举(40%)、性活动(19%)和驾驶(14%)特别担心。

结论

一级预防和二级预防ICD接受者的生活质量无显著差异。设备接受者的生活质量与已公布的全国范围内类似年龄非ICD患者的生活质量估计值相当。大多数一级和二级预防患者对ICD高度接受。

相似文献

1
Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era.一级预防治疗时代植入式心脏复律除颤器接受者的生活质量
Pacing Clin Electrophysiol. 2007 Apr;30(4):463-71. doi: 10.1111/j.1540-8159.2007.00694.x.
2
Use of beta-blockers in patients with an implantable cardioverter defibrillator.β受体阻滞剂在植入式心脏复律除颤器患者中的应用。
Ann Pharmacother. 2009 Jul;43(7):1189-96. doi: 10.1345/aph.1M140. Epub 2009 Jun 30.
3
[Sexual dysfunction, depression and quality of life in male implantable cardioverter defibrillator (ICD) recipients--with and without shock delivery].[植入式心脏复律除颤器(ICD)男性受者的性功能障碍、抑郁与生活质量——有或无电击治疗]
Harefuah. 2007 Aug;146(8):594-8, 647.
4
Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.植入心脏复律除颤器的患者在用于心脏性猝死一级预防与二级预防时的生存率及适当的设备干预情况。
Pacing Clin Electrophysiol. 2009 Mar;32 Suppl 1:S16-20. doi: 10.1111/j.1540-8159.2008.02222.x.
5
Health-related quality of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients.植入式心脏复律除颤器患者与起搏器接受者的健康相关生活质量比较。
Europace. 2006 Mar;8(3):168-74. doi: 10.1093/europace/euj052. Epub 2006 Feb 7.
6
Costs and quality-of-life effects of implantable cardioverter-defibrillators.植入式心脏复律除颤器的成本及生活质量影响
Am J Cardiol. 2006 Nov 15;98(10):1409-15. doi: 10.1016/j.amjcard.2006.06.041. Epub 2006 Oct 4.
7
Deactivation of implantable cardioverter-defibrillators: results of patient surveys.植入式心脏复律除颤器的去激活:患者调查结果。
Europace. 2013 Jul;15(7):963-9. doi: 10.1093/europace/eus432. Epub 2013 Feb 27.
8
Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study.植入式心脏复律除颤器与生活质量:非缺血性心肌病治疗评估研究中除颤器的结果
Arch Intern Med. 2007 Nov 12;167(20):2226-32. doi: 10.1001/archinte.167.20.2226.
9
A Comparison of ICD implantations in the United States versus Italy.美国与意大利植入式心律转复除颤器(ICD)植入情况的比较。
Pacing Clin Electrophysiol. 2007 Jan;30 Suppl 1:S143-6. doi: 10.1111/j.1540-8159.2007.00625.x.
10
Psychological and clinical problems in young adults with implantable cardioverter-defibrillators.植入式心脏复律除颤器青年患者的心理及临床问题
Kardiol Pol. 2008 Oct;66(10):1050-8; discussion 1059-60.

引用本文的文献

1
Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Surgically Repaired Tetralogy of Fallot.植入式心脏复律除颤器在法洛四联症外科修复中的成本效益
Pediatr Cardiol. 2025 Mar 21. doi: 10.1007/s00246-025-03833-5.
2
Comparative Effectiveness of Implantable Defibrillators for Asymptomatic Brugada Syndrome: A Decision-Analytic Model.无症状性Brugada综合征植入式除颤器的比较有效性:一项决策分析模型
J Am Heart Assoc. 2021 Aug 17;10(16):e021144. doi: 10.1161/JAHA.121.021144. Epub 2021 Aug 13.
3
Comparative Study between Subcutaneous and Endovascular Defibrillator Recipients Regarding Tolerance to the Implant Procedure and Perception of Quality of Life.
皮下和血管内除颤器接受者在植入手术耐受性和生活质量感知方面的比较研究。
Arq Bras Cardiol. 2021 Jun;116(6):1139-1148. doi: 10.36660/abc.20190312.
4
Patient and Partner Sexual Concerns During the First Year After an Implantable Cardioverter Defibrillator: A Secondary Analysis of the P+P Randomized Clinical Trial.患者和伴侣在植入式心脏除颤器后第一年的性关注:P+P 随机临床试验的二次分析。
J Sex Med. 2020 May;17(5):892-902. doi: 10.1016/j.jsxm.2020.01.028. Epub 2020 Mar 18.
5
Perceptions and experiences of patients living with implantable cardioverter defibrillators: a systematic review and meta-synthesis.植入式心脏复律除颤器患者的认知与体验:一项系统综述与元整合分析
Health Qual Life Outcomes. 2016 Nov 17;14(1):160. doi: 10.1186/s12955-016-0561-0.
6
Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator.一级和二级预防指征对植入式心脏复律除颤器焦虑情绪的影响。
J Arrhythm. 2016 Apr;32(2):102-7. doi: 10.1016/j.joa.2015.10.002. Epub 2015 Nov 19.
7
Psychosocial impact of implantable cardioverter defibrillators (ICD) in young adults with Tetralogy of Fallot.先心病法洛四联症患者植入式心脏转复除颤器对心理社会的影响。
Clin Res Cardiol. 2012 Jul;101(7):509-19. doi: 10.1007/s00392-012-0420-x.
8
Geographic variation in implantable cardioverter-defibrillator use and heart failure survival.植入式心脏复律除颤器使用和心力衰竭生存的地域差异。
Med Care. 2012 Jan;50(1):10-7. doi: 10.1097/MLR.0b013e3182293510.
9
Clinical and psychological impact of prophylactic implantable cardioverter-defibrillators in a community heart failure population.社区心力衰竭人群中预防性植入式心脏转复除颤器的临床和心理影响。
Ir J Med Sci. 2011 Jun;180(2):369-74. doi: 10.1007/s11845-010-0659-z. Epub 2010 Dec 14.
10
A review of health utilities using the EQ-5D in studies of cardiovascular disease.使用 EQ-5D 在心血管疾病研究中评估健康效用。
Health Qual Life Outcomes. 2010 Jan 28;8:13. doi: 10.1186/1477-7525-8-13.